Search

Virbac SA

Deschisă

SectorSănătate

354 -0.56

Rezumat

Modificarea prețului

24h

Curent

Minim

354

Maxim

355

Indicatori cheie

By Trading Economics

Venit

82M

Vânzări

738M

P/E

Medie Sector

22.544

88.032

Randament dividend

0.41

Marjă de profit

11.162

Angajați

6,365

EBITDA

157M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+9.82% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.41%

2.26%

Statistici piață

By TradingEconomics

Capitalizare de piață

3B

Deschiderea anterioară

354.56

Închiderea anterioară

354

Sentimentul știrilor

By Acuity

67%

33%

331 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Virbac SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 dec. 2025, 22:20 UTC

Principalele dinamici ale pieței

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec. 2025, 17:31 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec. 2025, 16:30 UTC

Principalele dinamici ale pieței

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec. 2025, 15:19 UTC

Principalele dinamici ale pieței

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec. 2025, 15:17 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec. 2025, 14:37 UTC

Principalele dinamici ale pieței

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 dec. 2025, 21:13 UTC

Achiziții, Fuziuni, Preluări

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 dec. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec. 2025, 17:16 UTC

Principalele dinamici ale pieței

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 dec. 2025, 17:00 UTC

Achiziții, Fuziuni, Preluări

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec. 2025, 15:57 UTC

Achiziții, Fuziuni, Preluări

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec. 2025, 15:02 UTC

Principalele dinamici ale pieței

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec. 2025, 14:40 UTC

Achiziții, Fuziuni, Preluări

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 dec. 2025, 13:01 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 dec. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 dec. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 dec. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 dec. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 dec. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Virbac SA Așteptări

Obiectiv de preț

By TipRanks

9.82% sus

Prognoză pe 12 luni

Medie 391.5 EUR  9.82%

Maxim 415 EUR

Minim 368 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVirbac SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

303.6 / 306.25Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Very Strong Bullish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

331 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
help-icon Live chat